Navigation Links
goBalto, Inc. expands Tracker 2.0's analytics and submissions features
Date:10/29/2013

SAN FRANCISCO, Oct. 29, 2013 /PRNewswire/ -- goBalto, Inc. announced today that the latest release of its signature product, Tracker 2.0, is now available.

With its 9th release, Tracker adds critical path reporting and a submissions manager. Now, clinical study managers can view the percentage of sites activated and the milestones blocking study startup completion, without having to wait for status reports that normally take up to a week.

The new critical path reports show all the documents and submissions along the critical path to key company milestones, and the overall status of all milestones for a study. There's a version that's suitable for country managers and another for printing and sending to sponsors.

The submissions manager allows specialists to plan and track documents to be included in an ethics or regulatory committee submission. A submission status report shows which study country and site documents are complete for a submission, and which ones are still in progress.

Jae Chung, founding CEO of goBalto, stated, "The life sciences industry is continually seeking ways to be more efficient in how they get their clinical studies started. Our new release focuses on innovation, going to the heart of how we can best help our partners quickly identify and resolve bottlenecks. In this critical phase of the process, our customers can't afford to wait multiple days for status or wonder how ready they are to complete a submission."

About goBalto

goBalto develops next-generation solutions that simplify how clinical trials are started in the pharmaceutical, biotechnology, and medical device industries. Our flagship product, Tracker, is a purpose-built software-as-a-service clinical research platform. It enables clinical trial sponsors and research organizations to track milestones on the critical path, and provides document workflow management capabilities in a transparent, regulatory-compliant, and user-friendly way. Founded in 2008 in Silicon Valley by biotechnology industry veteran Jae Chung, goBalto is backed by leading health technology investors. For more information, visit www.gobalto.com.

CONTACT: Maria Breaux, 415 994 5040, mbreaux@gobalto.com

Video with caption: "goBalto CEO and founder Jae Chung introduces the latest release of Tracker 2.0. With this release, Tracker adds critical path reporting and a submissions manager. Now, clinical study managers can view the percentage of sites activated and milestones blocking study startup completion, without having to wait for status reports that normally take up to a week. The submissions manager allows study startup specialists to specify country and site documents to include and track in a submission package." Video available at: http://youtu.be/JqvCJ2dehD0


'/>"/>
SOURCE goBalto
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Private Hospital Group in Spain Expands Radiotherapy Capabilities with Countrys First Elekta Versa HD System
2. Predilytics Secures Additional Funding and Expands Board of Directors
3. Indivumed Sells Inostics, the plasma-DNA Company, to Sysmex and Expands its Clinical Research Service and Patient Diagnostics Business
4. Trovagene Expands NPM Patent Coverage
5. Lupin Expands US Pediatric Brands Portfolio
6. SeraCare Life Sciences Expands R&D Facilities
7. Sam Solakyan Successfully Expands Vital Imaging Across California
8. American Cancer Society Expands Efforts to Reduce Burden of Cancer in Underserved Communities
9. SottoPelle expands its East Coast Presence
10. UBM Medica US Expands Network to Include Pharmacology and Psychopharmacology
11. Kush Bottles Expands Free and Same Day Delivery to Encompass More of Washington State
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... ITASCA, Ill. , June 23, 2016  In a startling ... states are failing their residents by lacking a comprehensive, proven plan ... , a definitive ranking of how states are tackling the ... rating to only four states – Kentucky , ... and Vermont . Of the 28 failing states, ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
(Date:6/23/2016)... today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate with operations headquartered in Bogota. ... ... ... ... Astellas is a ...
Breaking Medicine Technology:
(Date:6/27/2016)... , ... June 27, 2016 , ... "FCPX editors can ... inside of Final Cut Pro X," said Christina Austin - CEO of Pixel Film ... Final Cut Pro X users can now reveal the media of their ...
(Date:6/27/2016)... KS (PRWEB) , ... June 27, 2016 , ... TopConsumerReviews.com ... retailers of Eyeglasses . , Millions of individuals in the United States and ... have become a way to both correct vision and make a fashion statement. Even ...
(Date:6/26/2016)... Carolina (PRWEB) , ... June 26, 2016 , ... ... of a new product that was developed to enhance the health of felines. The ... centuries. , The two main herbs in the PawPaws Cat Kidney Support ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... Austin ... of the American College of Mohs Surgery and to Dr. Russell Peckham for medical ... and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern ... Laude and his M.D from the David Geffen School of Medicine at UCLA. He ... Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program ...
Breaking Medicine News(10 mins):